Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma.

ABSTRACT:

SUBMITTER: Wang JN 

PROVIDER: S-EPMC8440023 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature